Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys + Ribavirin for 24 vs 48 Weeks in HCV Genotype 1
NCT00629967Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2005
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Apr 2005; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00629967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629967.